For the other family with two mutations (BRCA1 and BRCA2), it has been possible to identify the separate routes of inheritance and hence to calculate the numbers of breast and ovarian cancers attributable to each mutation. This evidence concerns the gene BRCA1 and ovarian carcinoma.